Food and Drug Administration issued warning letters to multiple websites for the unlawful sale of unapproved and misbranded drugs to United States consumers over the Internet: www.d-pharmacy of Singapore www.mysteroidsmarket.com of Israel www.portmeds.com of the United States www.plakini-pharma.com of Malaysia Senators Ted Budd (R-NC) and Martin Heinrich (D-NM) introduced an amendment to the 2026 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act to ensure that the FDA is able to use its existing regulatory authority to prevent illicit weight loss products from getting into the country
Because theres a risk of user error, there is an increased chance of dosing errors
A settlement that finalized in 2025 required Cerebral to pay out $5 million to aggrieved customers who could not cancel their subscriptions, as well as to cease misusing and improperly disclosing patient information, misrepresenting its data privacy or security practices and misrepresenting its cancellation practices. Now, it seems, Robertson is allegedly continuing these practices, with new companies, and new names
While it still plays a role in energy metabolism, its main advantage lies elsewhere
It has also been shown to promote weight loss in certain patients, although that is not its intended use
Recently, data from the SURMOUNT-1 trial showed that tirzepatide treatment resulted in up to 22.5% weight loss in adults with obesity or overweight, who did not have diabetes at baseline [39]
